ReviewArchives of microbiology2026
Microbial architects of cigar fermentation: a critical review of beneficial roles in quality enhancement and detrimental potential for mould spoilage.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cigar tobacco fermentation is a microbially driven process that transforms raw tobacco leaves into a product with distinctive sensory attributes, yet the current understanding of the microbial roles in this process remains fragmented between descriptive community surveys and isolated mechanistic studies, with beneficial and detrimental microbial functions rarely integrated into a unified risk-benefit assessment. This review critically examines the microbiology of cigar fermentation through a dual-axis framework organized around beneficial metabolic functions and detrimental spoilage potential, each resolved into microbial identity, biochemical mechanism, and environmental modulation dimensions. We synthesize evidence from culture-dependent and culture-independent studies on microbial community assembly and succession, where Bacillus, Staphylococcus, and Aspergillus emerge as core fermentation genera, and evaluate the complementary three-pathway system - macromolecular enzymatic degradation, targeted biotransformation of tobacco alkaloids and polyphenols, and de novo biosynthesis of aroma-active volatiles - that drives flavor and quality enhancement. We further analyze the contrastive microbial balance governing tobacco-specific nitrosamine (TSNA) formation, where nitrate-reducing bacteria compete with nitrate-assimilating and nitrite-scavenging microorganisms to determine the net TSNA load. In parallel, we critically examine the mould spoilage microbiology of cigar fermentation, identifying the environmental thresholds - humidity above 80% RH, water activity above 0.85, and inadequate aeration - that select for mycotoxigenic Aspergillus and Penicillium species producing aflatoxins and ochratoxin A at levels that persist into the finished product. We survey emerging biotechnological strategies spanning bioaugmentation with defined starter cultures, biostimulation through environmental optimization, and biocontrol of spoilage fungi, and identify five critical research gaps - including the absence of gnotobiotic fermentation models and the predominance of correlative over causal studies - that must be addressed to translate microbial ecology into predictable fermentation biotechnology. By integrating microbial ecology, fermentation biochemistry, spoilage prevention, and applied biotechnology, this review is intended for researchers in tobacco microbiology and fermentation science, as well as cigar manufacturers, quality-control practitioners, and biotechnologists seeking microbiome-based strategies for quality improvement and risk mitigation.
Indexed as
Identifiers
42554875What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.